PT-141

PT-141 – Research Applications Overview

PT-141, also known as bremelanotide, is a synthetic cyclic peptide studied as a melanocortin-receptor agonist. Current research focuses on its activity at the MC3R and MC4R receptors within the central nervous system. Unlike compounds that act mainly through peripheral pathways, PT-141 is explored for its central signaling profile and its role in melanocortin pathway investigations.